Idun Pharmaceuticals

IDUN Pharmaceuticals is a private biotechnology firm focused on developing drugs that target apoptosis, mediated cell death in diseases related to cancer and inflammation.

IDUN was founded by Larry Bock and Drs. Larry Fritz, John Reed and Robert Horvitz.

IDUN was acquired by Pfizer in 2005 for an undisclosed amount of money, although news sources put the purchase price around $200m.[1]

References

  1. ↑ "Pfizer acquires Idun Pharmaceuticals". Outsourcing-pharma.com. Retrieved 2012-08-03.


This article is issued from Wikipedia - version of the 1/7/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.